Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis.

Ghonge A, Samperio VM, Hamoud M, Dasanu CA

Open source

DOI
10.1080/14712598.2026.2693759
Published
2026 Jun
Container
Expert opinion on biological therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14712598.2026.2693759,
  title = {Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis.},
  author = {Ghonge A and Samperio VM and Hamoud M and Dasanu CA},
  year = {2026},
  journal = {Expert opinion on biological therapy},
  doi = {10.1080/14712598.2026.2693759},
  url = {https://doi.org/10.1080/14712598.2026.2693759}
}

RIS

TY  - JOUR
TI  - Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis.
AU  - Ghonge A
AU  - Samperio VM
AU  - Hamoud M
AU  - Dasanu CA
PY  - 2026
JO  - Expert opinion on biological therapy
DO  - 10.1080/14712598.2026.2693759
UR  - https://doi.org/10.1080/14712598.2026.2693759
ER  - 

APA

A, G., VM, S., M, H., & CA, D. (2026). Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis.. Expert opinion on biological therapy. https://doi.org/10.1080/14712598.2026.2693759

Source records